ANDA 202984, held by Ph Health. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 202984 (Clonidine Hydrochloride), held by Ph Health, was first approved by FDA on Sep 30, 2013, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 2013 | Original application | Approved |
| Clonidine Hydrochloride0.1MG · tablet, extended release;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.2MG · tablet, extended release;oral | Clonidine Hydrochloride | Discontinued |
| Aug 4, 2020 | Supplement 9Labeling · Standard review | Approved | None posted |
| Aug 4, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 29, 2016 | Supplement 4Labeling · Standard review | Approved | None posted |
| Mar 29, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 30, 2013 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters